XSIRA PHARMA

What this means for you

This application is over — abandoned 26 Oct 2006. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

78501254

Mark type

Stylized text

Filed

18 Oct 2004

Published for opposition

31 Jan 2006

Abandoned

26 Oct 2006

Attorney of record

Bassam N. Ibrahim

Goods and services

• Class 001 — Chemicals: CHEMICAL-RELATED PRODUCTS, NAMELY, CHEMICAL ADDITIVES FOR USE IN THE MANUFACTURE OF PHARMACEUTICALS AND THE MANUFACTURE OF MEDICAL DIAGNOSTIC ASSAYS FOR USE IN HIGH THROUGHPUT AND HIGH CONTENT SCREENING FOR CLINICAL AND MEDICAL LABORATORY USE
• Class 005 — Pharmaceuticals: FULL LINE OF PHARMACEUTICALS; MEDICAL DIAGNOSTIC ASSAYS FOR USE IN HIGH THROUGHPUT AND HIGH CONTENT SCREENING FOR CLINICAL AND MEDICAL LABORATORY USE
• Class 042 — Scientific and technological services: LICENSING OF PATENTED TECHNOLOGY IN THE PHARMACEUTICAL AND LIFE SCIENCES FIELD; MEDICAL AND PHARMACEUTICAL RESEARCH SERVICES; AND LABORATORY RELATED RESEARCH IN THE FIELD OF LIFE SCIENCES

Owner

• XSIRA PHARMACEUTICALS, INC., MORRISVILLE, NC, US
• XSIRA PHARMACEUTICALS, INC., MORRISVILLE, NC, US
• Norak Biosciences, Inc., Morrisville, NC, US

Prosecution history

• 05 Jan 2007 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
• 05 Jan 2007 — ABANDONMENT - NO USE STATEMENT FILED
• 09 May 2006 — NOTICE OF ALLOWANCE CORRECTION ENTERED
• 08 May 2006 — FAX RECEIVED
• 25 Apr 2006 — NOA MAILED - SOU REQUIRED FROM APPLICANT
• 05 Apr 2006 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
• 31 Jan 2006 — PUBLISHED FOR OPPOSITION
• 11 Jan 2006 — NOTICE OF PUBLICATION
• 16 Dec 2005 — LAW OFFICE PUBLICATION REVIEW COMPLETED
• 09 Dec 2005 — ASSIGNED TO LIE
• 05 Dec 2005 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 03 Dec 2005 — AMENDMENT FROM APPLICANT ENTERED
• 15 Nov 2005 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 15 Nov 2005 — PAPER RECEIVED
• 20 May 2005 — NON-FINAL ACTION E-MAILED